Pierluigi Gasparini
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
141
Citations
5,579
Est. group size
~3
Recurring co-author estimate
Active years
40
Publishing since 1987
Pierluigi Gasparini's research focuses on small RNA molecules called microRNAs and their role in cancer biology, particularly how they influence tumor cell behavior such as the transition between epithelial (stationary) and mesenchymal (migratory) cell states. Much of the available public record centers on a single detailed study of how a gene called TWIST1 induces a microRNA (miR-424) that affects tumor initiation and progression. This work would suit students interested in molecular mechanisms of cancer spread and gene regulation by non-coding RNAs.
Publication output was modest and fairly steady from 2017-2022 but shows an unusual sharp spike in 2023, likely reflecting a single detailed publication with many linked supplementary materials, followed by very limited activity afterward.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Figure S6 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S5 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S2 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Table S1 - S2 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Data from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S3 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Data from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S4 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S7 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S3 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure Legends and Extended Methods from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S4 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S2 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S8 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Supplementary Figure S1 from TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
2023
- Cancer Research×7
- Proceedings of the National Academy of Sciences×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Cell Death and Differentiation×2
- The Journal of Experimental Medicine×2
- Paolo Fadda
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Rosario Distefano
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Giovanni Nigita
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Gian Luca Rampioni Vinciguerra
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Xinna Zhang
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile